Results 171 to 180 of about 1,734 (194)

In vitro studies of the impact of maribavir on CMV-specific cellular immune responses

Journal of Clinical Virology, 2016
Terry Stevens-Ayers, Michael Boeckh
exaly  

Foscarnet/ganciclovir/maribavir

Reactions Weekly, 2013
openaire   +1 more source

Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo

Antiviral Research, 2012
Morgan Hakki
exaly  

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients

Transplant Infectious Disease, 2010
Francisco M Marty
exaly  

Foscarnet/maribavir/valganciclovir

Reactions Weekly
  +4 more sources

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients

Journal of Infectious Diseases
sophie Alain, Jens D Lundgren, Martha Fournier   +2 more
exaly  

In vitro metabolic and transporter profiling for maribavir (SHP620)

Drug Metabolism and Pharmacokinetics, 2019
Devin Welty, Kefeng Sun, Haojing Rong, Ivy Song   +3 more
openaire   +1 more source

Foscarnet/Maribavir

Reactions Weekly
openaire   +1 more source

Pharmacokinetics of Maribavir, a Novel Oral Anticytomegalovirus Agent, in Subjects With Varying Degrees of Renal Impairment

Journal of Clinical Pharmacology, 2007
exaly  

Letermovir/Maribavir

Reactions Weekly
openaire   +1 more source